Home › DEALTALK: Game may not be over for Royalty' Pharma's bid for Elan
 

Keywords :   


DEALTALK: Game may not be over for Royalty' Pharma's bid for Elan

2013-06-28 14:54:12| Biotech - Topix.net

The game may not yet be over for U.S investment firm Royalty Pharma in its months-long pursuit of Elan Corp. The Irish drugmaker earlier this month rejected a hostile bid by Royalty worth up to $8 billion.

Tags: for game bid royalty

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
More »